London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: Mr.Picky, 26 Mar 2024 07:54
Last post: boxthefox, 8 Jun 2024 08:08
What are the issues with the new scanning technology at airports?
Any thoughts on why this share is dead in the water?
Mr p how was the the webinar? I’m thinking about adding here.
SMIN. Surprise change in CEO. Sales, profits, margins and cash generation all look OK. Dividend up 5% and a share buy-back programme. No need to worry here; will come back if the webcast has anything noteworthy in it.
Started: boxthefox, 5 Feb 2024 11:47
Last post: Grezzz, 13 Feb 2024 14:47
Certainly moving back to the 'top-up zone' now...
I have been tracking this share for awhile. I am ready to make a purchase because I think their prospects are good but the share price seems to be falling and I don't understand why? Does anyone else have an insight as to why this is the case.
Started: Mr.Picky, 26 Sep 2023 10:26
Last post: Grezzz, 26 Sep 2023 12:05
Thanks for the summary. Market seems to be saying 'boring' too! ;)
I joined the on-line presentation given by Paul Keel and Clare Scherrer following the results which were a tad better than expected. Sales, margins, ROCE and cash conversion all up, a strong balance sheet and progress on ESG but somehow.......boring! Claire was clear that the deployment of the capital generated was to the business first and shareholder second. The dividend was raised a slightly miserly 5.1% and the share buy back programme from the sale of medical is complete.
Guidance for FY24 is revenue plus 4-6% and an improvement in margins. We we directed to this coming more in the second half (how often have i heard that!) partly because of the business cycle at Smiths Interconnect and the higher margins on maintenance than OE at Smiths Detection which should be coming through later. Claire would not commit to 100% cash conversion but said there should be an improvement on this year's 86%.
All in all most satisfactory, however I experienced a smugness about the results from Paul which I don't think they merited.
Started: Uncle_Doug, 18 Jan 2023 12:41
Last post: TerryMC1, 19 May 2023 07:12
Plenty of recent Director Buys and absence of silly comments on here have persuaded me to venture into the unknown.
Nice RNS
Started: Schatzy57, 8 Apr 2022 12:57
Last post: volcano, 23 Sep 2022 09:02
get in ,looking good
No, you had to buy them before the ex dividend date
Hi, I purchased some Smiths shares yesterday. Will I be eligible for a dividend as the 7th is the ex div date?
Started: Troajan, 3 Apr 2022 09:21
Last post: Troajan, 3 Apr 2022 09:21
On 11 November 2021, Smiths Group plc ("Smiths Group") announced its intention to commence a share repurchase programme of Smith Group's ordinary shares (the "Ordinary Shares") up to a maximum consideration of £742 million (the "Programme"). The purpose of the Programme is to reduce the share capital of Smiths Group. The effect of the reduction in share capital will be to return 55% of the initial cash proceeds from the sale of Smiths Medical to shareholders.
Paultp yes I do from rns
The first tranche of the Programme will commence on 19 November 2021 and is expected to end by no later than 18 March 2022
Smith & Nephew PLC said Thursday that it is targeting 4%-6% consistent organic revenue growth by 2024 and set a new commitment to return surplus capital to shareholders through regular share buybacks.
The U.K. medical-technology company said that it expects to buy back between $250 million and $300 million of shares next year.
S&N said it plans to maintain higher investment in innovation to drive organic growth and continue buying new technologies, while expanding in higher growth segments.
Anyone have any clue about the time it will take to complete this share buy back?
Started: papucel, 28 Oct 2021 15:42
Last post: papucel, 28 Oct 2021 15:42
Everyone, I got the link from another board who triggered a petition against shorting
You may be interested to sign it as well so please circulate to all boards you are on and they are affected
https://www.change.org/p/department-for-business-energy-industrial-strategy-make-short-selling-of-shares-illegal
Got in at 1396 div 2mr sweet
New Low today (YTD) . What's going on ?
Smiths Group has found a buyer, ICU Medical, prepared to pay $0.4B more for the Medical division, plus a $0.1B earn out.
Market seemed to like the news and if it hadn’t been a red day all round this would have closed up 5%.
Started: Notmyjob, 31 Aug 2021 17:52
Last post: usually_right, 31 Aug 2021 20:18
recent director buying not far from current levels, i see value here. and certainly worth adding to on any weakness below 14 quid.
It looks like SGE are committed to buying around 10% of their shares back.
ULVR and BAE around 3%.
According to today’s RNS there will be a £715M share buy back programme. That’s just over 12% of the mcap.
Be interesting to see how that figure compares with recent buy backs on the FTSE 100 eg SGE, ULVR, BAE…
Last post: Paxlgl, 26 Aug 2021 11:12
Very low price and large buys at end of last few days. Some one is topping up for a divi?
Started: caitlin1, 24 Aug 2021 11:00
Last post: papucel, 25 Aug 2021 10:24
They haven't announced how much as the completion is not yet done. I guess we have to wait for few months until they see all the paper work and cash in.
Anyone know how much the special divi will be.Ive quite alot of shares here.
Started: fatprofits, 21 Aug 2021 13:17
Last post: Notmyjob, 21 Aug 2021 16:13
The company are selling its medical division for £1.7B but the following paragraph on the RNS seems to have gone unnoticed:
The Smiths board (the "Board") proposes a significant return of capital to shareholders following the successful completion of the Proposed Transaction.
A few on Thursday, looks interesting Imv.
Started: AshyG, 18 Aug 2021 18:50
Last post: AshyG, 18 Aug 2021 18:50
Hi guys, any idea when the special dividend is? As the sale of the medical division should be done or almost finished by now. Correct me if I am wrong please.
Thanks in advance.
Started: caitlin1, 18 Aug 2021 09:51
Last post: Paxlgl, 18 Aug 2021 12:19
What kind of divi?
It's all about the special divi.
Started: Notmyjob, 4 Aug 2021 10:54
Last post: Notmyjob, 4 Aug 2021 10:54
Paul Keel has just bought 25 000 shares costing over £350k.
Started: xxxAccountant, 4 Aug 2021 08:06
Last post: Notmyjob, 4 Aug 2021 10:07
And with a soon to be improved balance sheet, which of course helps negotiations.
Totally agree it won’t happen for a while but Smiths is now more specialized so more attractive.
Even more so now. Affordable and merging with a similar business will create synergies
Started: Grezzz, 2 Aug 2021 23:07
Last post: usually_right, 3 Aug 2021 20:00
the price was quite low. a day after a quite rich meggit takeover, the mkt was a bit underwhelmed and to be honest the shares had held up well against sector weakness. so they didnt break the bank but smiths have been struggling with the medical business and they do retain a minority stake in the business which can become something material in a few years. in the near term the energy sector should have performed well given the high oil price and thus related activity, while the aviation side you expect should have seen the worst by now. going forward it all depends on whether they can boost margins but i dont think there is a great deal of downside as there was talk of a full take out earlier this year and you cant rule out the americans coming in again for whats now a smaller smiths.
Surprised about the scale of the drop given that this news was expected.
The board obviously see better growth opportunities elsewhere and so we must trust their strategy as they hopefully have their finger on the industry pulse.
because of the spin off and takeover speculation, the shares didnt really follow cyclicals lower in the recent correction. anything below 14 quid puts them back in line and then some, so think 13-14 quid makes a good addition.
Agree with KSP. I think also, that despite this event being on 'slow-burn', the final announcement came as a surprise - hence the knee-jerk reaction. Opportunity to top-up!
Over done by the market for a news that that has been known since 2020! As usual drop the share price to buy in and make the quick bucks.....Company is going to be better off with £1.7 billion and still having a 30% stake in the new spin off...
Last post: usually_right, 12 Jul 2021 18:32
explains why the shares have outperformed over the last month. i was hoping to add to my position on weakness but despite a lower ft100, these shares have stayed firm.
Started: usually_right, 13 May 2021 20:05
Last post: usually_right, 13 May 2021 20:05
held the 200 day ma and then a great reaction off it later on. the 15 quid level takes you back as far as july last year. the next leg of the cyclical trade should see these make a new post covid high.
Started: BeardedDragon, 19 Nov 2020 09:15
Last post: Uncle_Doug, 26 Mar 2021 13:27
Good results (again!) Should return to pre Covid levels before too long.
Looks a very good set up on chart to rise a lot higher .
gla
Very surprised that today's announcement in press that Govt is to increase defence spending by £16 billion has not impacted those shares most likely to be affected. I am buying Smiths Group and Meggitt today.
Started: Uncle_Doug, 30 Jun 2020 17:56
Last post: sharehunter3, 24 Sep 2020 12:25
more of a dip ,had been hoping ,for move back upwards , how many who researching smin might be liking this lower share price better
still many share buys coming in ,sme liking this current price , have been watching covid test maker ncyt more recently with news on new test due ,like the potential here at smin ,in my view smin a share worth watching
after dip ,how many ,might be seeing ,a dip with share price as an opportunity
Stunning trading report. Not many companies will post increased revenue to 31st May 2020. good one to buy and tuck away for a couple of years.
Started: volcano, 21 Mar 2020 11:54
Last post: volcano, 21 Mar 2020 11:54
UK's Smiths makes ventilator available to other producers
Sat, 21st Mar 2020 11:17Thomson Reuters
LONDON, March 21 (Reuters) - British technology firm Smiths
Group said it was making one of its ventilators
available for other manufacturers to produce, part of a
coordinated attempt to tackle a shortage of life-saving
equipment as coronavirus spreads.
The group's Smiths Medical unit was providing intellectual
property and advice to other companies to make its PARAPAC
Plus lightweight ventilators, and it was ramping up its own
production at its site in Luton, just north of London.
Smiths said it was also talking to contract manufacturers to
add production capacity in the United States and elsewhere.
"We are doing everything possible to substantially increase
production of our ventilators at our Luton site and worldwide,"
its chief executive, Andrew Reynolds Smith, said.
Smiths said it was working with suppliers to increase
production over the next two weeks.
Smiths is a member of one of three consortia of companies
set up by Britain's government to speed up production of
ventilators.
The three teams are led by aerospace engineer Meggitt
and carmakers McLaren and Nissan. European
planemaker Airbus has offered help with 3D technology
and facilities if other companies need it.
(Writing by William Schomberg, editing by Ed Osmond)
Last post: B00oooM, 19 Mar 2020 15:51
aint got time for a indepth research. only put £400 inno.
its just dropped like all others from 16 quid
You do realise that they are demerging the medical equipment business after years of poor performance?
for a medical equipment bisness. should go to 12 pounds easily
I just bought a load
Worth buying at this level I feel
motleyfool
too cheap to ignore right now. Its earnings multiple is reasonable and its dividend is decent, but what particularly draws me to the stock is its discount to the sum of the value of the group’s parts.
Dated 21st SEPTEMBER 2018
Today’s full-year results from Smiths show a mixed picture. Currency headwinds caused revenue to fall by 2% to £3,213m last year. And headline pre-tax profit fell by 8% to £487m.
However, the company says that on an underlying basis — excluding various one-off factors such as acquisitions and disposals — earnings per share of 90.7p represent a 4% increase on the previous year.
I’m normally cautious about such wide-ranging adjustments, but in this case I think they are fair. Analysts expect underlying earnings to rise by about 10% this year, and I don’t see any reason to doubt this.